We are proud to announce that Dr. Robert S. Langer, founder of 40 biotechnology companies, including Moderna, will join the company’s Board of Directors. He will assist Galen Robotics to advance and deliver a new, breakthrough generation of cooperative surgical robots for microsurgery while also launching Digital-Surgery-as-a-Service (a new shared-risk mode for hospitals to procure surgical...
We are proud to announce that Acquisition International Magazine has named Galen Robotics Maryland’s 2021 Leading Innovators in Surgical Robotics Solutions! As a company, we continued to democratize microsurgery and robotic surgery. Galen is developing collaborative surgical robots for microsurgery unaddressed by today’s surgical robots. The vision is to introduce an affordable, per-usage digital surgery “as-a-service” model....
The COVID-19 pandemic has brought radical change to the structure of healthcare operations, causing medical institutions to reevaluate their distribution of resources to better care for their patients and adapt to new economic conditions in a more dynamic economic environment. In this article for MD+DI, Galen Robotics CEO Bruce Lichorowic discusses the potential for shared-risk...
At Galen, we believe collaborative robots that enhance surgical performance are key to the future of robotic surgery. Interestingly, our vision is the same as many industry experts. Read More from the new UK Royal Academy of Surgeons Robotics Whitepaper In the article, experts see the opportunity of collaborative robots that enhance surgical performance. “Collaborative...
Galen CTO David Saunders will represent Galen Robotics as a speaker at the MD&M West Conference from August 10th-12th, 2021. MD&M West, presented by Informa Markets, brings together MedTech engineers, business leaders, disruptive companies, and innovative thinkers to create powerful solutions and life-changing medical devices. Dave will present twice at this conference, once for a...
The healthcare sector is struggling from the combined pressure of skyrocketing costs, as well as the need to continuously improve the quality of services and results. The Covid-19 pandemic only exacerbated the challenge. As a result, new healthcare business models – including Surgery-as-a-Service – are being evaluated and gaining traction. Read our latest article featured...
Galen Robotics, Inc. CEO Bruce Lichorowic took the opportunity to present the technical foundations of the Galen platform as well as the key supporting information and commercialization initiatives intended to ensure that the innovations from Galen will provide tangible improvements in procedure safety and patient health. In this presentation you’ll learn details about the following:...
“Galen wants to offer their robots on a service model to negate healthcare institutions’ high outlay costs. When offered as-a-service, they believe the greater versatility and wider application of surgical robots could spur a new demand level.” Read the full article featured on Kaspersky: https://bit.ly/3gsjbBv
The COVID-19 pandemic brought with it a range of unexpected challenges that affected emerging and established firms in the surgical robotics industry alike, as rapid shifts in capital deployment and procedure demand took place to effectively combat the crisis. However, Galen Robotics leaned on the strength of its technical basis and the support of dedicated...
Surgical robotics have been and continue to be an area of intense focus for medical technology firms and healthcare providers alike, with the potential to radically improve patient outcomes by introducing capabilities that an unaided surgeon cannot consistently maintain. However, certain factors, such as high capital expenditures and a lack of application diversity, have limited...